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Abstract
Indole  and indolizines  (heterocyclic  aromatic  compounds  structurally  and chemically
isomeric with indoles) are an important class of N-fused heterocyclic compounds due to
their interesting biological and optical properties. Different strategies for generating di‐
verse collections of small molecules with indole and indolizine moieties have been de‐
veloped. They can be synthesized by means of classical and nonclassical pathways. The
present study discusses the versatile nature of indole/indolizine derivatives, new green
methods for their synthesis, their possible mechanism of action and also provides infor‐
mation about current/future prospects of the topics and different indole/indolizine de‐
rivatives  in  pharmaceutical/clinical  trials.  With  the  remarkable  number  of  approved
indole-containing drugs as well  as  the importance of  the indolizine moiety,  it  can be
easily concluded that indole and indolizine derivatives offer perspectives on how pyr‐
role scaffolds might be exploited in the future as bioactive molecules against a broad
range of diseases.
Keywords: Indole, indolizine, bioactive heterocycles, green chemistry, functionalization,
mechanism
1. Introduction
A great deal of research in heterocyclic chemistry concerns the development of strategies for
efficient synthesis and the discovery of new methods of ring formation, since more than half
of the biologically active compounds produced by nature contain a heterocyclic moiety as a
fundamental unit in their structure. Also, heteroaromatic compounds are always of great
importance for chemists and the identification and confirmation of highly potent and selective
bioactive molecules is a decisive step both in academic and pharmaceutical research.
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Attribution License (http://creativecommons.org/licenses/by/3.0), which permits unrestricted use, distribution,
and reproduction in any medium, provided the original work is properly cited.
Heterocyclic compounds with a pyrrole cycle are significant both in materials and in medicinal
chemistry [1]. Indoles and indolizines (heterocyclic aromatic compounds structurally and
chemically isomeric with indoles) are important classes of N-fused heterocyclic compounds
due to their interesting biological and optical properties. Although their chemistry is a well-
established subject for researchers, they continue to attract much attention due to their diverse
biological properties. Also, the correlation between indoles and indolizines has prompted
speculation that indolizine analogs of biologically important indoles could conceivably have
potent physiological activities [2].
Indoles and their derivatives are well-known as an important class of heterocyclic compounds,
their core being a near-ubiquitous component of biologically active natural products, wide‐
spread in different species of plants, animals, and marine organisms. The indole is also well-
known as one of the most important scaffolds for drug discovery, capable of serving as ligand
for a diverse array of receptors and it has been a major focus of research [3]. Indole derivatives
have the unique property of mimicking the structure of peptides and to bind reversibly to
enzymes and exhibit significant physiological and pharmacological, industrial, and synthetic
applications such as beneficial estrogen metabolism promoter in humans, anticarcinogenic
properties, inhibitors of human prostate cancer cells, and free radical scavenging activities [1,
4]. The indole scaffold is widely used in antiviral drugs and reverse-transcriptase inhibitors,
drugs used to treat HIV infection or AIDS, and in some cases hepatitis B. Meanwhile, a number
of bis (indolyl) alkanes have received considerable attention because of their occurrence in
bioactive metabolites of terrestrial and marine origin [5].
Indolizine is the core structure of many of the naturally occurring alkaloids such as swainso‐
nine (a potent inhibitor of Golgi alpha-mannosidase II, an immunomodulator and a potential
chemotherapy drug), monomorine (might be used to lure ants to their doom), gephyrotoxin
(muscarinic antagonist), and lamellarins (HIV-1 integrase inhibition and antibiotic activity) [6].
The indolizine synthetic derivatives also deserve special attention because of their pharmaco‐
logical  properties  such  as  antibacterial,  anti-inflammatory,  antiviral  and antileishmanial,
analgesic and antitumor, antioxidant activities, aromatase inhibition, calcium entry block‐
ing,  histamine  H3  receptor  antagonist,  and  physicochemical  properties  such  as  strong
fluorescence [6, 7].
Different strategies for generating diverse collections of small molecules with indole and
indolizine moieties have been developed. They can be synthesized by means of classical and
nonclassical pathways.
The development of simple, convenient, and an eco-friendly approach for the synthesis of these
biologically important compounds is still in demand. For example, the very useful and green
concept of a “click” reaction is a facile, selective, high-yield reaction under mild water-tolerant
conditions with little or no by-products [8]. Cascade annulation reactions lead also to the
formation of polycyclic fused six- and seven-membered heterocycles with indole and indoli‐
zine core [9].
Microwave irradiation, sonication, and solvent-free are green chemistry techniques that have
been used for a variety of applications including organic synthesis. Microwaves and ultra‐
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sounds have been used as synthetic techniques for obtaining indole and indolizine derivatives
in high-yield, higher reaction rate. The simplicity of the reactions using these techniques, the
elimination of toxic solvents, and the synthesis carried out in a very short time period are
particularly useful for the creation of diverse chemical compounds of “drug-like” molecules
for biological screening [10].
Multicomponent reactions (MCRs) or tandem reactions have developed as a powerful tool for
delivering the molecular diversity needed for the synthesis of interesting heterocyclic scaf‐
folds, to efficiently construct a variety of intermediates possessing an indolyl or indolizyl
subunit and are particularly attractive especially if they start from simple molecules [11].
The present study discusses the versatile nature of indole/ indolizine derivatives, new green
methods for their synthesis, their possible mechanism of action, and also provides information
about current/future prospects of the topics and different indole/indolizine derivatives in
pharmaceutical/clinical trials.
2. Indoles
Indole derivatives are, perhaps, the most studied nitrogen heterocyclic systems because of
interesting biological properties that received particular interest due to the reserpine alkaloid,
one of the first drugs used for the treatment of central nervous system (CNS) disorders.
Different substituted indoles are particularly important in pharmaceutical chemistry being
capable to bind many receptors with high affinity exhibiting various pharmacological
activities. Therefore, it is important to explore new synthetic reactions and evaluate various
properties of indole derivatives.
2.1. Indole synthesis
To obtain biologically relevant N-hydroxyindoles, a prudent step would be to synthesize O-
protected hydroxyindoles, to avoid their dimerization into kabutanes. Such were the premises
of one study, presenting the annulation of nitrosoarenes with various alkylating and acylating
agents, able to afford the desired compounds with excellent regioselectivity [4].
The synthesis of 3,3-dimethyl-2-amide indoles could be achieved through the I2/DMSO
promoted oxidative amidation reaction between 1,2,3,3-tetramethyl-3H-indolium iodide and
secondary amines with moderate yields (Figure 1) [12].
Using a method involving four steps, 2-indole-3-yl-thiochroman-4-ones could be obtained
(Figure 2), according to Song et al. In the final step, the Michael addition reaction of thiochro‐
mone and indole, an ionic liquid is used, to increase the yield, with the added advantage that
it could be reused three times without a decrease of efficiency [13].
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Figure 2. Synthesis of 2-indole-3-yl-thiocroman-4-ones derivatives [13]
2.2. Green methods for indole synthesis
Polyvinylsulfonic acid, a biodegradable and recyclable polymeric acid rarely used in organic
transformations, could be used as a Bronsted acid catalyst in the synthesis of bis (indolyl)
methane [14]. Another pathway to obtain this compound would be to employ a reusable resin,
Indion Ina 225H, as catalyst of the substitution reaction between indoles and aldehydes (Figure
3), reportedly attaining excellent yields in short reaction times [15].
Figure 3. Synthesis of bis(indolyl) methane using a reusable resin, Indion Ina 225H [15]
Various carbonyl compounds, including ketones could also be building blocks for the much
desired bis(indolyl)methanes, using catalytic amounts of iodine in the presence of sodium
dodecylsulfate in aqueous solution above its critical micellar concentration and the protocol
was also extended to afford 3-substituted indolyl ketones (Figures 4 and 5) [3].
Figure 1. Synthesis of 3,3-dimethyl-2-amide indoles: mechanism [12]
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Figure 4. Synthesis of bis(indolyl)methanes, using catalytic amounts of iodine in the presence of sodium dodecylsul‐
fate [3]
Figure 5. Iodine-catalyzed formation of bis(indolyl) methane from indole and aldehyde under aqueous micelar condi‐
tions [3]
3. Indolizine derivatives
The indolizine core has found numerous applications in the synthesis of biologically active
compounds. Partially or completely reduced indolizine analogs are widely used in the
synthesis of indolizidine alkaloids and related unnatural products. Among many other
pharmacological uses, polycyclic analogs of indolizine, for example, have found a broad
application as heterocyclic analogs of indene in the synthesis of ligands for transition metal
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complexes. Although many methods have been developed for their synthesis, they are
generally time-consuming or require the use of stoichiometric amounts of organometallic
reagents, Lewis acids, expensive catalysts or potentially toxic solvents, which limits their
economical applications. Accordingly, development of alternative catalytic methods for
construction of these important heterocyclic cores is necessary [9].
3.1. Indolizines obtained via 1,3-Dipolar cycloaddition
The mechanism of obtaining condensed five-membered ring systems via 1,3-dipolar cycload‐
ditions implies the reaction of a dipole, in this case an N-ylide generated in situ from a
cycloimmonium halide and a base or another deprotonating agent followed by its addition to
a dipolarophile, olefinic, or acetylenic [7].
N-ylides could be generated employing 1,2-epoxybutane as both solvent and deprotonation
agent, or by using triethylamine in DCM, with ethyl propiolate or DMAD as dipolarophiles,
or again coupling the ylide with acrylonitrile and using TPCD for the aromatization step, all
methods with similar medium to good yields (Figure 6) [7]. Moderate yields, up to 22%, are
reported when reacting DMAD with N-ylides generated from pyridinium salts and K2CO3,
using catalytic amounts of dicyclohexyl-18-crown-6 [16]. In another study, 20 substituted
indolizines were obtained in just 30 min at room temperature, employing electron-deficient
alkynes, in the presence of K2CO3 in DMF, with yields as high as 77% [17].
Figure 6. Synthesis of the new 7,8,9,10-tetrahydropyrrolo[2,1-a]isoquinolines [7]
The solvent could have a great impact on the reaction mechanism, as one study demonstrates,
using substituted ethenes (E-1,2-di(alkylsulfonyl)-1,2-dichloroethene) as dipolarophiles
(Figure 7). In aprotic solvents, the reaction takes place as a 1,3-dipolar cycloaddition, with
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yields between 62 and 75% for the six indolizines obtained, but in protic solvents an addition–
elimination reaction intervenes, leading to the competitive formation of furans, with indolizine
yields as low as 9% [18].
Figure 7. The reactions of pyridinium ylides with ethenes in EtOH [18]
3.2. Indolizines obtained via one-pot reactions
One-pot reactions imply obtaining the product in a single step, by adding all the necessary
reagents in the same reaction medium, without having to isolate and purify any precursors of
the desired product. This type of procedure offers advantages such as swiftness, the prepara‐
tion of complex compounds from readily available material, simplification of workup and
atom economy.
Mishra et al. present a method to obtain 1-aminoindolizines from aldehydes, secondary
amines, and terminal alkynes, in a one-pot reaction (Figure 8). After testing several solvents
and metal catalysts, the best results are obtained with CuCl in PEG, synthesizing 15 substituted
indolizines with yields exceeding 70%, after 3–4 h reaction time [19].
Substituted 3-aminoindolizines could be obtained via one-pot multistep reactions, from 2-
pyridine carboxyaldehide and various nitriles, after 3 h reaction in toluene at 105°C, by adding
1.1 eq of Hantzsch ester as a hydride transfer agent and catalytic amounts of piperidinium
acetate [20].
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The synthesis of 2-acetyl-3-(phenylamino)indolizine-1-carboxamides could also be achieived
in a single step (Figure 9), by combining pyridine-2-carbaldehyde, acetoacetanilide and
isocyanides in toluene at reflux, with yields around 90% for the four compounds obtained [21].
Figure 9. Synthesis of 2-acetyl-3-(phenylamino)indolizine-1-carboxamides via a three-component condensation [21]
A four-component tandem reaction is proposed by Zhenjun et al., by treating pyridine (or
quinoline) with phenacyl bromides (or bromoacetophenones), ethyl glyoxalate, and Na2CO3
in refluxing acetonitrile. The resulting polysubstituted indolizines are obtained after 16 h of
reaction time in moderate-to-good yields [22].
Seventeen polysubstituted indolizines could be obtained via a one-pot sequential addition-
cyclodehydration-dehydrocyanation from of 2-(1H-pyrrol-1-yl) nitriles with α,β-unsaturated
carbonyl compounds (Figure 10) [23].
Figure 10. One-pot addition-cyclodehydration-dehydrocyanation of 2-(1H-pyrrol-1-yl) nitriles with α,β-unsaturated
carbonyl compounds [23]
Figure 8. One-pot multicomponent synthesis of 1-aminoindolizines [19]
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3.3. Novel approaches to indolizine synthesis
The  indolizine  core  could  be  accessible  starting  from  pyrrole,  with  strategies  involving
intramolecular aldol cyclization or domino Knoevenagel condensation, shown in Figure 11 [24].
Figure 11. Possible synthetic approaches to indolizines [24]
Another [3+3] annulation approach employs allyl bromides derived from Morita-Baylis-
Hilman adducts (Figure 12), with the conclusion that electron withdrawing groups, as
substituents at the aromatic ring, contribute to successful ring closure and result in accordingly
substituted indolizines [25].
Figure 12. Design of new [3+3] annulation route to indolizines [25]
Novel 2-acyl-6-aryl substituted indolizines were obtained starting from 4-acyl-pyrrole-2-
carbaldehyde and α, β-unsaturated esters, in the presence of K2CO3 in DMF, with yields
between 42 and 68% after 8–12 h at 50°C [26].
Another possibility would be to perform a tandem oxidative C-H functionalization and 5-
endo-dig cyclization, starting from 2-substituted pyridines and alkynes (Figure 13), which
could be achieved with good yields using an Ag2CO3 reusable catalyst [27].
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Figure 13. Silver-mediated oxidative C-H functionalization to synthesize indolizines [27]
Substituted pyridines and acetophenones lead to the formation of 1,2,3-triarylindolizines with
moderate-to-excellent yields, promoted by I2/DMSO at 100°C, the proposed mechanism for
this reaction is presented in Figure 14 [28].
Figure 14. Formation of 1,2,3-triarylindolizines. Proposed reaction pathway [28]
3.4. Green methods for indolizine synthesis
During the synthesis of N-heterocycles there are many problems of health and safety in
addition to the environmental problems caused by their use and disposition as waste. Green
methods are a route towards increasing the efficiency of indoles and indolizines synthesis, and
stride to use less toxic solvents, to reduce the stages of the synthetic routes and minimize waste
as far as practically possible for sustainable development.
A potential method to make synthetic chemistry more environment-friendly would be to reuse
catalysts, such as ion-exchanging resins. Amberlite-IRA 402 (OH) could be employed as the
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ylide-forming base in the reaction between phenacyl pyridinium, quinolinium and isoquino‐
linium salts and alkynes (Figure 15) [29].
Figure 15. Synthesis of indolizines and pyrrolo [1,2-a] quinolines using alkynes [29]
Unconventional activation techniques, such as microwave irradiation, not only lead to shorter
reaction times but generally increase the purity of the desired compound. One study presents
the synthesis of 8 indolizine derivatives in an aqueous medium that were obtained in good
yields after 1 min of irradiation at 300W [30].
Biocatalysis could be employed to aid the formation of indolizine derivatives in an aqueous
medium, as seen in Figure 16. Ultrasound activation was compared to conventional heating,
affording 7,7′-bis-indolizines with similar yields in much shorter reaction times [31].
Figure 16. Synthesis of bisindolizines by biocatalytic reaction [31]
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4. Indoles and indolizines functionalization
The Oxone-induced oxidation of indole-3-carbaldehydes and 5-halogenated analogs could
lead to the formation of tryptanthrin derivatives (Figure 17), a highly functionalized biologi‐
cally active natural product, at room temperature [32]. The phthalazine moiety could also be
accessible with green methods, employing catalytic amounts of L-proline, with good yields
and less than 2 h reaction time [33].
Figure 17. Tryptanthrin derivative [32]
The reaction between indole and formaldeyde could produce high yields of hemiaminals, with
the added value of mild conditions, such as room temperature and an aqueous medium, in
the presence of TBAF [34].
The most eco-friendly approach when it comes to solvent choices would be not to employ any
solvents. Analogs of 3-alkylindole, for example, could be prepared in solvent-free conditions,
using MgO nanoparticles as catalyst [35]. Bis(indol-3-yl)methanes could be synthesized in
solvent-free grinding conditions, employing a reusable catalyst, phosphate-impregnated
titania, obtaining yields as high as 93% [36].
Figure 18. Synthesis of highly functionalized indolylpyrans [37]
Unconventional activation techniques could also be used for indole functionalization. Within
10 min, including reaction and purification time, 3-pyranyl indole derivatives could be
obtained with good yields, through one-pot microwave-assisted reactions, with InCl3 as
catalyst (Figure 18) [37]. Indolyl chalcones could be prepared from indole-3-carboxaldehyde
and heteroaryl active methyl compounds under conventional heating, but the yield was much
improved and reaction time was drastically reduced (from more than 9 h to less than 15 min)
when microwave irradiation was introduced [38]. Ultrasounds aid the selective formation of
Scope of Selective Heterocycles from Organic and Pharmaceutical Perspective126
11 3-selanylindole derivatives with good yields, proving superior to conventional heating and
microwave irradiation for this synthesis [39].
Both indoles and indolizines could be functionalized via alkylation with enamides under mild
conditions (Figures 19 and 20), using FeCl3, in short reaction times with good yields [2].
Figure 19. Iron-catalyzed alkylation of indoles with enamides [2]
Figure 20. Iron-catalyzed alkylation of indolizines with enamides [2]
The Friedel-Crafts alkylation of indoles could also be performed in water, as presented in
Figure 21, with yields as high as 97% in the presence of Keggin heteropoly acids, solid super-
acid catalysts [40].
Figure 21. Friedel-Crafts alkylation of indole [40]
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A novel approach presents the previously inaccessible regioselective formation of substituted
pyrido[2,3-b]indolizine-10-carbonitriles, via a cascade transformation of α,β-unsaturated
carbonyl compounds with a dimer of 1-(cyanomethyl) pyridinium chloride, in ethanol/water
in the presence of sodium acetate [41].
5. Pharmaceutical applications
As we have seen so far, interesting pathways have been proposed for the synthesis of indoles
and indolizines. Many of these molecules have subsequently been involved in tests to assess
their biological activity. Natural compounds with these moieties have also attracted interest,
not just as extracts, but as targets for total/semisynthesis or as frameworks for compound
libraries. Next, we shall review some of the extremely diverse pharmaceutical applications of
these derivatives, ranging from fluorescence probes, to antiviral, to anticancer molecules
currently in clinical trials.
5.1. Natural and synthetic indoles
Lead by Cialis, there are seven indole-containing commercial drugs in the Top-200 Best Selling
Drugs by US Retail Sales in 2012. Examples of indole derivatives marketed as antiviral drugs,
for example, are Arbidol (a broad-spectrum antiviral with anti-influenza and immunomodu‐
lating effects) and Delavirine (a non-nucleoside reverse transcriptase inhibitor) [42].
Bisindoles, such as hamacanthin A, isolated from marine sponges (Hamacantha sp., Spongosor‐
ites sp.), or the more famous indole-3-carbinol (I3C), a compound found in cruciferous
vegetables (cabbage, kale, cauliflower, broccoli, Brussels sprouts) and its bisindole metabolite,
3,3'-diindolylmethane (DIM), have displayed biological activities such as antimicrobial,
antiparasitic, anti-inflammatory, and anticancer and are high up on the interest list of many
researchers [43].
Figure 22. Natural indoles [50]
Some of the many studies published in this field have resulted in the elucidation of some of
the mechanisms of their bioactivity. The influence of I3C, for example, on lung cancer cells,
has been attributed to apoptosis via Fas activation and caspase-8 pathways and also cell-cycle
arrest at the G0/G1 phase, and it was also shown that cancer preventive effects of I3C were
mediated via modulation of the phosphatidylinositol-3-kinase (PI3K)/Akt signaling pathway
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[44]. I3C was also shown to induce the expression of phase I and II enzymes by the binding of
the aryl hydrocarbon receptor (AhR) (Figure 23) [45].
Figure 23. Biological activity pathways of indoles [45]
DIM has been found to increase bone mass by supressing osteoclastic bone resorption, in
physiological and pathological conditions [46]. DIM could also help prevent heart failure, as
one study indicates the compound improves myocardial energy metabolism imbalance via
AMPKα signaling [47].
Strychnine and brucine are well known for their toxic effect that manifests in the form of
hypertension and violent convulsions. Brucine is also a proposed anticancer drug candidate,
as it inhibits VEGF-induced cell proliferation, reducing p-VEGFR2 kinase activity and
inhibiting neovascularization in vivo [48].
Other indole alkaloids, isolated from marine sources, such as coscinamides, dragmacidin D,
topsentins, or even fungal sources, such as asterriquinone, have exibited antiviral (anti-HIV),
antimicrobial, antitumor activity, along with the inhibition of serine–threonine protein
phosphatases or ascites hepatoma AH13, for example [49]. Such compounds, isolated from the
Strychnos species, have also been found to inhibit quinine- and choloquinine-resistant P.
falciparum [50]. One of the more studied indole alkaloids would be physostigmine, the template
that led to the development of rivastigmine, globally licensed in 2006 to fight the symptoms
of dementia associated with Parkinson's disease, also prescribed for the symptomatic treat‐
ment of Alzheimer’s disease [51].
Figure 24. Indole alkaloids – strychnine, brucine, asterriquinone, physostigmine, and rivastigmine[50]
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With methods of extraction developing since the 1960s, with many efforts concentrating on
the efficiency and environmental impact of the process, terpenoid indole alkaloids and their
pharmacological  properties  continue  to  attract  attention  as  some  of  them  are  already
marketed as anticancer, antihypertensive, or hypoglycemic agents, for example [52]. Some
monoterpene indole alkaloids are in high demand, such as vinblastine (Catharanthus roseus)
and camptothecin (Camptotheca acuminata, Nothapodytes foetida), currently used as chemother‐
apic drugs, and eyes have turned toward metabolic engineering. However, their biosynthet‐
ic pathways are still not fully elucidated and geneticians, chemists, and biotech specialists
are scrambling to fill in the gaps, with resources such as cell- and organ-specific transcrip‐
tome databases on hand [53, 54].
Figure 25. Indole alkaloids – vinblastine and camptothecin [50]
A novel class of indole-2-carboxylate derivatives was designed starting from the structure of
pyrroloquinoline quinone, with two compounds (Figure 26) emerging as more potent anti‐
proliferants than the reference drugs, compounds that induced PARP cleavage and increased
ROS generation dose-dependence [55].
Figure 26. Indole-2-carboxylate derivatives [55]
Protein tyrosine phosphatases (PTP) are a novel, mostly untapped family of therapeutic
targets, with implications in oncology (SHP2), autoimmunity (Lyp) or diabetes (PTP1B). X-ray
crystal structural analysis has been performed on PTP-inhibitor complexes, revealing bicyclic
benzofuran and indole-based salicylic acids as useful first steps toward the development of
more potent inhibitors (Figure 27) [56].
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Figure 27. PTP-inhibitor [56]
Novel galantamine derivatives with indole moiety have exhibited an activity against acetyl‐
cholinesterase up to 95 times higher than the parent compound, with one promising lead
binding in a region close to the peripheral anionic site of the enzyme, where the Ω-loop of
amyloid beta peptide adheres [57].
Coronary heart disease, prevalent in industrialized regions, comes hand-in-hand with high
levels of LDL-C (”bad cholesterol”) and low levels of HDL-C (”good cholesterol”), treated
mostly with statins, inhibitors of HMG-CoA reductase with dose-limiting hepato- and
myotoxicity. However, the screening of a small indole chalcone fibrates library (Figure 28) has
revealed three compounds with a more potent hypolipidemic effect than the standard drug,
fenofibrate, coupled with high inhibition percentages of superoxide anions, hydroxyl radicals,
and microsomal lipid-peroxidation [58].
Figure 28. Indole chalcone fibrates [58]
Beneficial effects on lipid and also glucose metabolism were also reported concerning 1-(4-
chlorobenzoyl)-5-hydroxy-2-methyl-3-indoleacetitic acid (GY3), which increased glucose
consumption and decreased lipid accumulation through AMPK activation in hepG2 cells, with
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obvious implications in metabolic syndrome, type 2 diabetes, and nonalcoholic fatty liver
disease [59].
Some indole derivatives also show promising antimicrobial activity. Five out of 24 bisindo‐
lylmethane Schiff base derivatives synthesized were found to specifically inhibit Salmonella
typhi, S. paratyphi A and S. paratyphi B, even if the inhibition was moderate at best, when nitro
or halogen substituents were introduced [43].
5.2. Natural and synthetic indolizines
Natural products derived from the indolizine core, such as castanospermine, swainsonine, or
tylophorine, polyhydroxylated indolizidine alkaloids, have attracted much attention, strug‐
gles toward total synthesis, or analog design issues. Their biological properties range from the
antiviral to the anticancer realm, with promising effects on autoimmune diseases [60].
Figure 29. Indolizidine alkaloids [50]
For example, castanospermine glycoside analogs inhibit breast cancer cells MCF-7 and MDA-
MB-231, inducing cell cycle arrest and apoptosis without impact on normal cell proliferation
[61]. Some 5α-substituted swainsonine analogs successfully inhibit Golgi alpha-mannosidase
II, a key enzyme in the N-glycosylation pathway and a potential target for cancer chemother‐
apy, without much loss of activity by comparison with the parent compound [62]. Tylophorine
was shown to inhibit VEGFR2 tyrosine kinase activity and its downstream signaling pathways,
neovascularization, tumor angiogenesis and tumor growth, molecular docking simulations
indicating that it could form hydrogen bonds and have aromatic interactions within the ATP-
binding region of the VEGFR2 kinase unit [63].
In the indolizine nucleus, the six-membered ring suffers from low electron density, with a
subsequent charge buildup in the five-membered ring, resulting in a large dipole moment and
fluorescence properties. The influence of the substituents goes a long way into predicting a
blue or red-shifted fluorescence; for example, the C-2 position could carry a lot of weight [26].
The 10π conjugated planar electronic structure, exhibiting strong fluorescence properties, can
be useful for DNA interaction studies. Such is the case of some indolizinylpyridinium
derivatives, found to interact similarly to ethidium bromide, binding in the minor groove, but
having its fluorescence partially quenched [64].
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Switchable biosensors could be designed starting from Seoul-Fluor (Figure 30), an indolizine
scaffold with three positions for different radicals: R1 and R2 substituents affect electronic
perturbation; R3 could be a functional handle for bioconjugation, thus creating a versatile
platform with tuneable emission wavelength and controllable quantum yield [65].
Figure 30. Indolizine biosensor: Seoul-Fluor [65]
Many indolizine derivatives have been proven to be worthy therapeutic agents, with a number
of them undergoing clinical trials, notably five anticancer molecules that inhibit topoisomerase
[66]. As is the case of photophysical properties, the substituents of the indolizine core can be
tailored to suit the bioactivity requirements.
Following a SAR study, 49 indolizine derivatives were obtained and tested as potential HIV-1
infectivity factor inhibitors, one of which was found to exhibit an IC50 value of 11 µM [67].
A feature that makes indolizine derivatives attractive is the design possibilities. The facile
replacement of substituents could lead to more in-depth perception toward their effect upon
desired bioactivity, solubility, or other properties sought [66].
Two new classes of indolizines fused with phenantroline skeletons were designed and
synthesized, obtaining compounds with a coplanar structure, potentially able to interact with
DNA through an intercalation mechanism, compounds that also possess good solubility in
microbiological medium. Furthermore, one of the compounds exhibit, under aerobic condi‐
tions, activity against M. tuberculosis H37Rv, with an IC50 = 67 µM. Two other compounds had
a selective and significant antiproliferative activity (around 50%) against two breast cancer cell
lines (MCF7 and T-47D) (Figure 31) [68].
Figure 31. Indolizines fused with phenantroline skeletons active against M. tuberculosis and breast cancer [68]
During rational design efforts, concentrated on the identification of potential farnesyltrans‐
ferase inhibitors (implications with respect to oncogenic Ras proteins), the replacement of the
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triazole unit with the indolizine nucleus resulted in IC50s in the low micromolar range. The
substituents’ influence on bioactivity and pharmacokinetic parameters was also investigated
[69].
Rational design could be pushed even further, employing 3D-QSAR studies to yield pharma‐
cophore models, as is the case for 15-lipoxygenase inhibitory activity. For this purpose, 47
indolizines with anti-15-LOX activity were used to obtain a statistically significant model [70].
The similarity of the two heterocycles has motivated researchers since 1967, when Harrell and
Doerge postulated that indolizine analogs of bioactive indoles could possess similar or
improved potency [66]. Such an endeavor was attempted with the synthesis of l-(2-aminoeth‐
yl)-3-benzyl-7-methoxy-2-methylindolizine, an analog of indole derivative benanserin, the
replacement of indole with indolizine proving to have no effect on anti-acetylcholinesterase
activity but diminished the antihistamine and anti-5-hydroxytryptamine activity [66].
Ramatroban, 3-((3R)-3-{[(4-fluorophenyl)sulfonyl]amino}-1,2,3,4-tetrahydro-9H-carbazol-9-
yl)propanoic acid, is a well-known prostaglandin D2 inhibitor and thromboxane receptor
antagonist. Researchers from Merck and Amira have presented numerous ramatroban analogs
with the indole moiety replaced with indolizine and aza-indole, both proving potential during
SAR studies. Among them, a 4-aza-indole derivative (Figure 32) inhibited hCRTH2 with an IC
of 6 nM and was active in a murine OVA-induced lung inflammation model [71-74].
Figure 32. Tricyclic CRTH2 antagonist [74]
LE 300 is a selective antagonist for dopamine D1/D5 and serotonin 5-HT (2A) receptors, bearing
an azecine ring fused to an indole ring on one side and a benzene moiety on the other side.
New analogs of this compound were prepared, namely pyrrolo[2,3-g]indolizine, pyrrolo[3,2-
a]quinolizine rings and their corresponding dimethylpyrrolo[2,3-d]azonine, and dimethyl‐
pyrrolo[2,3-d]azecine [75]. The study concludes that the indolizine and quinolizine derivatives
show no activity concerning the receptors analyzed, while their azonine and azecine counter‐
parts exhibited only weak antagonistic effects for serotonin and histamine receptors, remain‐
ing nonresponsive toward the four dopamine receptors tested.
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Secretory phospholipases A2 (sPLA2s) is successfully inhibited by substituted indole and
indolizine derivatives, as previously reported by Lilly and Shinogi researchers, with com‐
pounds like indoxam and Me-indoxam exhibiting favorable pharmacokinetic profiles [76-79].
Oslund et al. have prepared a set of benzo-fused analogs, among which they identified a
compound that was the first reported potent inhibitor of groups IID and IIF sPLA2s and the
most generally potent sPLA2 inhibitor reported to date (Figure 33) [80].
Figure 33. Substituted indole, indolizine, and benzo-fused indole inhibitors against human and mouse sPLA2 [80]
James et al. have prepared a series of indole and indolizine-glyoxylamides (Figure 34) and
subsequently tested the compounds’ cytotoxicity against cancer cell lines, identifying high
antiproliferative activities, even in the case of multidrug-resistant phenotypes. After searching
among numerous cores, with the goal to replace indole, the researchers synthesized a novel
class of cancer agents with an indolizine core, with a lead compound that proved effective
against multidrug-resistant cell lines such as MES-SA/DX5 and HL60/TX1000, resistant to
treatment with Taxol [81].
Figure 34. Indole- and Indolizine-glyoxylamide derivatives [81]
6. Conclusions
Considering the growing interest for biologically active compounds, we believe that in the
future the search for novel indole and indolizine derivatives will result in the emergence of
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new synthesis pathways and new and unexplored biologically active derivatives with pyrrole
moieties.
Taking into account the importance of anticancer drugs, like vinblastine, irinotecan, topotecan,
or camptothecin, the development of biologically active derivatives of new natural lead
compounds containing indole and indolizine nucleus might be helpful in the design and
development of novel and more potent anticancer drugs, antiviral agents, intercalating agents.
With the remarkable number of approved indole-containing drugs as well as the importance
of the indolizine moiety, it can be easily concluded that indole and indolizine derivatives offer
perspectives on how pyrrole scaffolds might be exploited in the future as bioactive molecules
against a broad range of diseases.
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